Adam Davies, Author at Recombinetics

About Adam Davies

This author has not yet filled in any details.
So far Adam Davies has created 113 blog entries.

Medical Alley Q3 Breakdown: All Major Sectors in Medical Alley Break $100 Million Raised for First Time

Medical Alley Q3 Breakdown: All Major Sectors in Medical Alley Break $100 Million Raised for First TimeAdam Davies2020-08-14T16:18:43-05:00

Recombinetics to channel more funding into animal gene editing business

Recombinetics to channel more funding into animal gene editing businessAdam Davies2020-08-14T16:18:57-05:00

NIH Awards $86 Million ($4M for 5 years to Recombinetics) to Improve Genome Editing Techniques

NIH Awards $86 Million ($4M for 5 years to Recombinetics) to Improve Genome Editing TechniquesAdam Davies2020-08-14T16:19:20-05:00

Developing Genome Editing Solutions for BTB

Developing Genome Editing Solutions for BTBAdam Davies2020-08-14T16:19:43-05:00

This Week in Dairy featuring Tad Sonstegard on gene editing

This Week in Dairy featuring Tad Sonstegard on gene editingAdam Davies2020-08-14T16:20:03-05:00

St. Paul gene editing firm, Mayo partner to grow human heart cells in pigs

St. Paul gene editing firm, Mayo partner to grow human heart cells in pigsAdam Davies2020-08-14T16:20:23-05:00

TARGET-TB with researchers to develop genome editing solutions for bovine tuberculosis

TARGET-TB with researchers to develop genome editing solutions for bovine tuberculosisAdam Davies2020-08-14T16:20:38-05:00

Recombinetics Announces Collaboration with Mayo Clinic to Grow Human Cardiomyocytes in Swine for Exo-transplantation

Recombinetics today announced a multi-project, collaborative research and development agreement with Mayo Clinic to advance capabilities to bioengineer human stem cells within swine models. The [...]

Recombinetics Announces Collaboration with Mayo Clinic to Grow Human Cardiomyocytes in Swine for Exo-transplantationAdam Davies2018-10-17T18:00:22-05:00

Scientists Team Up to Tackle Cattle Tuberculosis

Scientists Team Up to Tackle Cattle TuberculosisAdam Davies2020-08-14T16:21:05-05:00

Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine Tuberculosis

Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine TuberculosisAdam Davies2020-08-14T16:21:23-05:00